FDA's OK Lets Bausch & Lomb Join Eye-Laser Price War
The Food and Drug Administration has approved Bausch & Lomb's (BOL Quote) Technolas 217 Excimer Laser System, bringing another corrective eye surgery laser machine into a highly competitive market currently engaged in a price war.
Bausch & Lomb said it would immediately begin marketing Technolas 217 in the U.S., selling the laser at a list price of $525,000 per unit. The Rochester, N.Y.-based company will collect a fee of $100 per procedure from doctors using the technology.| |
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,464.40 | 1,110.63 | 2,176.05 | 32.79 |
Oil *
77.05
|
|
UP
30.69
|
UP
4.98
|
UP
6.87
|
DOWN
0.38
|
10 Yr
3.28%
SPDR Gold
116.62
|
|
+0.29%
|
+0.45%
|
+0.32%
|
-1.15%
|
Data delayed 20 minutes |














